Hot Biotech Stocks For 2019

Is a stock market pullback on the way? Maybe. And even if not now, it’s inevitable that the market will take a breather at some point in the future.

Smart investors will be ready to take advantage of a market pullback, whenever it comes and offers discount prices on great stocks. Three drug stocks appear to be excellent choices to buy on a dip: AbbVie (NYSE:ABBV), Allergan (NYSE:AGN), and Celgene (NASDAQ:CELG). Here’s why.

Image source: Getty Images.

AbbVie: A dividend hunter’s dream

AbbVie is already inexpensive, with shares trading at only 10 times expected earnings. If the overall market drops and pulls the biotech stock down with it, AbbVie will be an even more attractive buy.

One nice benefit of scooping up AbbVie stock at a discount is that you can lock in at a really juicy dividend yield. The current dividend yield of 3.9% would move higher as the biotech’s share price goes down.

Hot Biotech Stocks For 2019: Take-Two Interactive Software, Inc.(TTWO)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    The week ahead includes earnings announcements from two major retailers, Home Depot (NYSE:HD) and Walmart (NYSE:WMT), and an updated look at video game publisher Take-Two Interactive’s (NASDAQ:TTWO)latest growth trends.

  • [By ]

    Ubisoft is a French gamer company headquartered in Montreuil, France, not to be confused with Montreal, Quebec. This firm has subsidiaries all over the world, and you know their titles. How about “Assassin’s Creed,” “Prince of Persia,” “Far Cry,” and the Tom Clancy names. Yup, all these are theirs. Actually, in terms of revenue and market cap, this firm is fourth place in the Americas and Europe, behind Activision, Electronic Arts (EA) , and Take-Two Interactive Software (TTWO) .

  • [By ]

    I’m talking about returns of 31%, 35%, and more — all in a matter of weeks rather than months or years. In fact, we just closed a trade on Take-Two Interactive (Nasdaq: TTWO) for a clean 38.9% in just over four weeks.

Hot Biotech Stocks For 2019: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Constant advances in technology require companies of all sizes to make efforts to keep up and take maximum advantage of new capabilities before competitors do. That puts companies like EPAM Systems (NYSE:EPAM) in a great position, because the resulting demand for IT services is constant and growing. EPAM did a good job of fulfilling its potential for strong growth in 2017, and the IT services specialist has high hopes that 2018 will bring even more gains.

Hot Biotech Stocks For 2019: CF Industries Holdings, Inc.(CF)

Advisors’ Opinion:

  • [By Max Byerly]

    CF Industries (NYSE:CF) had its target price trimmed by Bank of America from $40.00 to $38.00 in a report published on Friday. The brokerage currently has an underperform rating on the basic materials company’s stock.